Psoriasis.
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN.
Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6.
Psoriasis Pathogenesis and Treatment.
Rendon A, Schäkel K.
Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475.
Psoriasis.
Boehncke WH, Schön MP.
Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Epub 2015 May 27.
Pathogenesis and clinical features of psoriasis.
Griffiths CE, Barker JN.
Lancet. 2007 Jul 21;370(9583):263-271. doi: 10.1016/S0140-6736(07)61128-3.
Risk Factors for the Development of Psoriasis.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M.
Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347.
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, Severino P, Souto EB, García ML, Pujol M, Sánchez-López E.
Int J Mol Sci. 2021 May 7;22(9):4983. doi: 10.3390/ijms22094983.
Psoriasis: epidemiology, clinical features, and quality of life.
Langley RG, Krueger GG, Griffiths CE.
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. doi: 10.1136/ard.2004.033217.
Management of psoriasis as a systemic disease: what is the evidence?
Korman NJ.
Br J Dermatol. 2020 Apr;182(4):840-848. doi: 10.1111/bjd.18245. Epub 2019 Oct 15.
European consensus statement on phenotypes of pustular psoriasis.
Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C, Barker JN; ERASPEN Network.
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1792-1799. doi: 10.1111/jdv.14386. Epub 2017 Aug 29.
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications.
Singh R, Koppu S, Perche PO, Feldman SR.
Int J Mol Sci. 2021 Nov 26;22(23):12793. doi: 10.3390/ijms222312793.
